Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Electric field strength |
---|---|---|---|---|
Murawska A et al. | 2024 | invertebrate, honeybee workers (<i>Apis mellifera carnica</i>) | electric field, 50/60 Hz | - |
Şenol N et al. | 2023 | animal, rat/ Wistar albino | electric field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
Li X et al. | 2019 | plant, soy bean (<i>Glycine max</i> L.) | electric field, 50/60 Hz, power transmission line | 2–10 kV/m |
Lin KW et al. | 2016 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/SB34 | RF, microwaves, electric field, magnetic field, 50/60 Hz | 20–205 V/m |
Dutta SK et al. | 1998 | intact cell/cell culture, chicken primary retina cells and NG108-15 cells (the cells result from the fusion of N18TG-2 mouse neuroblastoma cells with C6BU-1 rat glioma cells) | electric field, low frequency, 50/60 Hz | 45.629–46.385 V/m |
Walter RJ et al. | 1997 | intact cell/cell culture, H9 cells (human leukemia cells) | electric field, 50/60 Hz, co-exposure | 10–3,000 mV/cm |
Lin H et al. | 1994 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line), transfected | electric field, magnetic field, 50/60 Hz, shielding/field deprivation | 50–500 µV/m |
Goodman R et al. | 1994 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) and yeast cells (<i>Saccharomyces cerevisiae</i>) | electric field, magnetic field, 50/60 Hz | 11 µV/m–6 mV/m |
Blank M et al. | 1992 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | electric field, 50/60 Hz | 3 mV/m |
Greene JJ et al. | 1991 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | electric field, magnetic field, 50/60 Hz | 0–3.4 mV/m |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.